
Panelists challenge the belief that testosterone fuels prostate cancer, explain PSA on therapy and TRAVERSE BPH data, and weigh Schedule III status.
Alexandria, VA--The search for a sensitive and specific screening tool for interstitial cystitis has been nothing short of elusive.





